tiprankstipranks
pc:altes

Altesa BioSciences

A clinical-stage pharmaceutical company focused on developing therapies for chronic lung diseases, including COPD and asthma. The company is advancing novel antiviral and respiratory treatments aimed at reducing respiratory exacerbations and improving patient outcomes.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$75M
Total Amount Raised$75M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$75M
Latest Funding Amount$75M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Feb 19, 2026
Series B
$75.00M

Investors

Investor Name
Funding Round
Series B
Series B
Series B
Series B

Related News and Analysis